Djaudat Idiyatullin1, Michael Garwood1, and Sergey Magnitsky2
1Center for Magnetic Resonance Research and Department of Radiology, University of Minnesota Medical School, Minneapolis, MN, United States, 2Radiology, UCSF, San Francisco, CA, United States
Synopsis
Synapsis. Mesenchymal Stem Cells (MSCs) have a high potential
for a treatment of bone diseases. We develop new acquisition protocol for the
detection of therapeutic cells in knee joints. Labeling MSCs with iron oxide
particles not only reduce T2* but also induce the resonance frequency shift of
labeled cells. This shift enabled us to implement tissue saturation scheme and
detect distinct hyperintense signal from grafted cells. New protocol allowed us
to detect and quantify therapeutic cells for six days after implantation which
was not possible before. Proposed protocol opens new opportunities for in vivo
monitoring of cell therapy of bone disorders.
Introduction
It has been shown histologically that Mesenchymal
Stem Cells (MSCs) have high potentials for a treatment of bone loss diseases
such as osteoporosis, osteoarthritis and bone fracture1,2. An injection of MSCs directly into
a knee joint has been suggested, as an effective delivery method of the
therapeutic cells. However, the fate of the grafted cells after administration
is unknown until histological staining. Our group is developing noninvasive
techniques to detect and quantify grafted cells overtime and to facilitate the translation
of promising preclinical results into the clinical. Conventional T2-weighted
MRI method was successfully implemented for the detection of iron labeled cells
in brain, spine and muscle tissues. However, this technique produces a
hypointense signal from both bones and grafted cells, which make the detection
and quantification of the therapeutic cells very challenging in musculoskeletal
systems. Our previous studies indicate that the SWIFT3 pulse sequence enables to produce a
hyperintense signal from iron labeled cells4. In this project, we modified
original SWIFT acquisition protocol and implemented new magnetization
preparation scheme. This scheme suppressed signal from the host tissue and
significantly improved in vivo
detection of the grafted cells.
Methods
Cell culture:
Mouse MSCs were maintained on uncoated flasks in media with DMEM and 10% FBS
and labeled with different concentration of Feraheme overnight5. Phantoms: To minimize bulk magnetic susceptibility gradients
spherical NMR tubes with different iron oxide solutions were immersed into
cylindrical NMR tube with pure water and a chemical shift of the iron solutions
relative to pure water signal was measured with a pulse-acquire sequence. All spectra and images were acquired at 9.4T animal
scanner (Agilent Technologies, USA). MSCs injection: 20 ml of iron-oxide labeled MSCs (200 μg/ml of Fe) were injected into the
knee joint of rats’ highlimbs. Imaging:
Radial 3D MBSWIFT images6 were acquired with 4-phase shifted hard pulses of 5.2 μs length (with 2.6 μs dead time), TR =
1.9 ms, excitation/acquisition bandwidths 192/384 kHz, number of views = 96000. Frequency selective RF pulse
(Gaussian, 7 ms, 90-degree flip angle) tuned to the water proton signal was
implemented for a tissue saturation.
Results
We discovered that the iron oxide
particles not only reduced the T2 relaxation time but also increased resonance frequency
of surrounding water molecules. NMR spectrum of an iron solution in a spherical
NMR tube and pure water exhibited two distinct signals (Fig.1A). The peak on
the left is the signal from iron-oxide solution while peak on the right is from
pure water. The shift of the proton frequency in the iron solutions was
linearly
proportional to the concentration of the iron oxide particles (Fig1.B)
This frequency shift opens an opportunity for us to saturate water signal from the tissue
without significant changes of the signal from iron labeled cells. Fig.2C shows
anatomical SWIFT image of rat knee joint, D – depicts this knee after
application of tissue saturation scheme, E – tissue saturated SWIFT image of the knee joint after administration of 4 x106 iron labeled MSC.
Hypointense signal from grafted cells was clearly detected in these
experiments. New imaging protocol allowed us to detect and quantify grafted
cells for six days after the administration.
Discussion
High
concentration of labeling contrast agent is very beneficial for the detection
of grafted cells. It provides stronger contrast and longer detection time of
the injected cells. In this study, we discovered that iron oxide particles
induced the chemical shift of protons signal from water molecules, which became
very significant at a high concentration of the contrast agent. The resonance
frequency shift produced by iron oxide particles allowed us to implement an
additional RF pulse and suppress the NMR signal from the normal tissue while
the signal from iron labeled cells remained unaffected. With our new method, we
were able to detect and quantify grafted MSC for six days after administration,
which was not possible before. Our new imaging protocol opens earlier not available opportunities to
monitor stem cell therapy in complex anatomical areas such as knee joints over
time. Our method should be applicable to any cell tracking
studies and can find many applications for stem- and immuno-therapies.
Acknowledgements
This
study was supported by NIH grants R21A06850 and P41 EB015894. We also would like to thank Tony Huynh for the help
with MRI acquisition and animal preparations. References
- Guan
M, Yao W, Liu R, et al. Directing mesenchymal stem cells to bone to augment
bone formation and increase bone mass. Nature
medicine 2012;18:456-62.
- Yao W, Guan M, Jia J, et al. Reversing
Bone Loss by Directing Mesenchymal Stem Cells to the Bone. Stem Cells 2013.
- Idiyatullin D, Corum C, Park JY, et al.
Fast and quiet MRI using a swept radiofrequency. J Magn Reson 2006;181:342-9.
- Magnitsky S, Idiyatullin D, Corum C, et
al. Imaging of Grafted Mesenchymal Stem Cells in Bone Tissue. Proc. Intl.Soc.Mag.Reson.Med.
2015;15:1020.
- Frank JA, Zywicke H, Jordan EK, et al.
Magnetic intracellular labeling of mammalian cells by combining (FDA-approved)
superparamagnetic iron oxide MR contrast agents and commonly used transfection
agents. Academic Radiology.
2002;9:S484-7.
- Idiyatullin D, Corum CA, Garwood M.
Multi-Band-SWIFT. J Magn Reson
2015;251:19-25.